Weber A, Toppari J, Harvey R D, Klann R C, Shaw N J, Ricker A T, Näntö-Salonen K, Bevan J S, Clark A J
Department of Endocrinology, St. Bartholomew's Hospital Medical College, London, United Kingdom.
J Clin Endocrinol Metab. 1995 Jan;80(1):65-71. doi: 10.1210/jcem.80.1.7829641.
Familial glucocorticoid deficiency is an autosomal recessive syndrome of adrenal unresponsiveness to ACTH characterized by glucocorticoid deficiency, high plasma ACTH levels, and a normal renin-aldosterone axis. Defects of the ACTH receptor have been suggested as a possible cause, and we have previously reported a number of novel mutations of the ACTH receptor gene in some, but not all, cases, suggesting that familial glucocorticoid deficiency may have a heterogeneous molecular etiology. Here we report the clinical features and ACTH receptor gene analysis in four patients from different families. We found that two patients were compound heterozygotes for the S74I and R128C mutations (patient A) and I44M and L192fs frame shift mutations (patient B). The other two patients (C and D) were of different ethnic ancestry, but were both homozygous for a R146H mutation. Segregation studies within families revealed heterozygosity in the parents and several other family members. Human CRH tests in the parents of patients A and B showed normal cortisol and ACTH responses in the S74I, R128C, and I44M heterozygotes and exaggerated cortisol and ACTH responses in the L192fs heterozygote, suggesting that the physiological ACTH increment induced in this test did not reveal evidence of subclinical ACTH resistance, and that this test may not be of value in ascertaining heterozygosity.
家族性糖皮质激素缺乏症是一种常染色体隐性遗传综合征,其特征为肾上腺对促肾上腺皮质激素(ACTH)无反应,表现为糖皮质激素缺乏、血浆ACTH水平升高以及肾素 - 醛固酮轴正常。ACTH受体缺陷被认为是可能的病因,我们之前报道了一些但并非所有病例中ACTH受体基因的新型突变,这表明家族性糖皮质激素缺乏症可能具有异质性分子病因。在此,我们报告来自不同家族的4例患者的临床特征及ACTH受体基因分析。我们发现2例患者分别为S74I和R128C突变(患者A)以及I44M和L192fs移码突变(患者B)的复合杂合子。另外2例患者(C和D)具有不同的种族血统,但均为R146H突变的纯合子。家族内的分离研究显示父母及其他一些家庭成员为杂合子。对患者A和B的父母进行人促肾上腺皮质激素释放激素(CRH)试验,结果显示S74I、R128C和I44M杂合子的皮质醇和ACTH反应正常,而L192fs杂合子的皮质醇和ACTH反应增强,这表明该试验中诱导的生理性ACTH增加未显示亚临床ACTH抵抗的证据,且该试验在确定杂合子方面可能无价值。